• Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
  
• Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
  

PubMed=17129361; DOI=10.1111/j.1349-7006.2006.00357.x; PMCID=PMC11159712
Shogo Ehata, Aki Hanyu, Makoto Fujime, Yoko Katsuno, Erina Fukunaga, Kouichiro Goto, Yuichi Ishikawa, Kimie Nomura, Hiroshi Yokoo, Toshiyuki Shimizu, Etsuro Ogata ...Show all 14 authors... , Kohei Miyazono, Kiyochi Shimizu, Takeshi Imamura; Show fewer authors
Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line.
Cancer Sci. 98:127-133(2007)

PubMed=18663362; DOI=10.1038/onc.2008.232
Yoko Katsuno, Aki Hanyu, Hidetoshi Kanda, Yuichi Ishikawa, Futoshi Akiyama, Takushi Iwase, Etsuro Ogata, Shogo Ehata, Kohei Miyazono, Takeshi Imamura;
Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
Oncogene 27:6322-6333(2008)

PubMed=26691676; DOI=10.3892/ijo.2015.3300
Hitomi Sudo, Atsushi B. Tsuji, Aya Sugyo, Hiroyuki Takuwa, Kazuto Masamoto, Yutaka Tomita, Norihiro Suzuki, Takeshi Imamura, Mitsuru Koizumi, Tsuneo Saga;
Establishment and evaluation of a new highly metastatic tumor cell line 5a-D-Luc-ZsGreen expressing both luciferase and green fluorescent protein.
Int. J. Oncol. 48:525-532(2016)